Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 84 OP08-38 | DOI: 10.1530/endoabs.84.OP-08-38

ETA2022 Oral Presentations Oral Session 8: Basic 2 (5 abstracts)

Brain effects of combined levothyroxine (T4) and 3-iodothyronamine (T1AM) replacement therapy in a murine model of hypothyroidism

Andrea Bertolini 1 , Caterina Ricardi 2 , Nicoletta Maria Grittani 2 , Chiara Ippolito 3 , Stefania Moscato 3 , Letizia Mattii 3 , Sabina Frascarelli 2 , Grazia Chiellini 4 , Alessandro Saba 5 , Riccardo Zucchi 5 & Grazia Rutigliano 6


1University of Pisa, Department of Pathology, Pisa, Italy; 2Department of Pathology, University of Pisa, Pisa, Italy, Italy; 3Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, Italy; 4University of Pisa, Pisa, Italy, Pisa, Italy; 5Department of Pathology, University of Pisa, Pisa, Italy; 6Scuola Superiore Sant’anna, National Research Council (Cnr), University of Pisa, Pisa, Italy


Adult-onset hypothyroidism is associated with cognitive dysfunction, and a significant fraction of hypothyroid patients still shows persistent disturbances despite standard T4 replacement therapy. Experimental results showed that tissue levels of T4 metabolites, particularly T1AM, are decreased in hypothyroidism and remain low after T4 replacement. Thyroid hormones are important for the promotion of neurogenesis and neuron migration to different areas of the cerebral cortex, including hippocampus, and it is known that hippocampus-dependent memory is impaired in the hypothyroid mice. We aimed to evaluate the effects of hypothyroidism and different replacement treatments on neurogenesis in the sub-granular zone of the dentate gyrus (SGZ). Six-week-old C57BL/6J male mice were given methimazole and potassium perchlorate (0.20 mg/g/die and 0.30 mg/g/die) in drinking water for 49 days while the control littermates received water. At day 21 mice were implanted with subcutaneous ALZET® osmotic pumps delivering replacement treatments for 28 days. Animals were divided in 4 groups: euthyroid; hypothyroid; hypothyroid treated with T4 (0.04 μg/g BW/die); hypothyroid treated with T4+T1AM (0.04 μg T4 & 0.004 μg T1AM/g BW/die). Specific markers were used to quantitate cell proliferation (Ki67) and the presence of neuroblasts/immature neurons (doublecortin-DCX) through immunofluorescence analysis performed in the SGZ. Then, following hippocampal RNA isolation, we analysed gene targets involved in neurogenesis pathway using a PrimePCR pre disegned 96-well collection panel (Bio-Rad). A 49-day period of adult-onset hypothyroidism induced a reduction of around 20% in the number of DCX positive newly generated cells. Compared to hypothyroidism, T4 treatment increased the number of cells by 45.58% (mean diff=-106.9: P<0.05) while the T4 + T1AM treatment produced a 58.20% increase (mean diff=-141.6: P<0.01). One-way ANOVA revealed a global significant effect among the 4 groups (P=0.003). Real time PCR highlighted significant changes in the expression of genes related to neurogenesis as ANOVA revealed an upregulation in the expression of Ngf, Kdr, Ntf3, Mapk1/3 and Neurog2 genes in T4+T1AM treated mice compared to T4 treated mice (P<0.05). Our results indicate that cognitive dysfunctions related to adult-onset hypothyroidism could be due in part to impaired hippocampal neurogenesis. Cellular markers and gene expression analysis suggest the presence of underlying molecular mechanisms activated only by the combination of T4 and T1AM. Further investigations are required to elucidate the potential pathophysiological and clinical relevance of these findings.

Volume 84

44th Annual Meeting of the European Thyroid Association (ETA) 2022

Brussels, Belgium
10 Sep 2022 - 13 Sep 2022

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.